Kezar Life Sciences Inc (KZR)
0.7633
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.7633
0.00 (0.00%)
After-Hours: 20:00
Kezar Life Sciences Cash from Investing (Quarterly): 20.41M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 20.41M |
December 31, 2023 | 27.88M |
September 30, 2023 | 18.57M |
June 30, 2023 | 13.20M |
March 31, 2023 | 16.39M |
December 31, 2022 | -8.661M |
September 30, 2022 | -24.71M |
June 30, 2022 | 1.51M |
March 31, 2022 | -59.53M |
December 31, 2021 | -82.49M |
September 30, 2021 | 38.48M |
June 30, 2021 | 16.25M |
March 31, 2021 | -0.687M |
December 31, 2020 | 17.32M |
September 30, 2020 | 2.79M |
Date | Value |
---|---|
June 30, 2020 | -37.28M |
March 31, 2020 | -39.33M |
December 31, 2019 | 1.678M |
September 30, 2019 | 15.62M |
June 30, 2019 | 2.142M |
March 31, 2019 | 0.976M |
December 31, 2018 | -9.916M |
September 30, 2018 | -56.67M |
June 30, 2018 | -17.12M |
March 31, 2018 | -0.195M |
December 31, 2017 | -0.063M |
September 30, 2017 | -0.326M |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-82.49M
Minimum
Dec 2021
38.48M
Maximum
Sep 2021
-3.022M
Average
2.466M
Median
Cash from Investing (Quarterly) Benchmarks
Accuray Inc | -0.795M |
Tonix Pharmaceuticals Holding Corp | -0.108M |
Acumen Pharmaceuticals Inc | -9.203M |
NovaBay Pharmaceuticals Inc | 1.068M |
Palatin Technologies Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -22.86M |
Free Cash Flow | -83.65M |
Free Cash Flow Per Share (Quarterly) | -0.314 |
Free Cash Flow Yield | -150.3% |